IRIS
GUIDOTTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 692
NA - Nord America 537
AS - Asia 71
OC - Oceania 1
Totale 1.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 536
SE - Svezia 528
IT - Italia 83
FI - Finlandia 27
SG - Singapore 25
DE - Germania 24
CN - Cina 23
IE - Irlanda 16
IN - India 8
ID - Indonesia 5
GB - Regno Unito 4
IR - Iran 4
FR - Francia 3
RO - Romania 3
TW - Taiwan 3
AT - Austria 1
AU - Australia 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
MK - Macedonia 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
UA - Ucraina 1
Totale 1.301
Salva come PNG Salva come JPEG
Città #
Lawrence 142
Princeton 142
Ashburn 118
Milan 42
Helsinki 27
Shanghai 19
Dublin 16
New York 16
Pune 8
Rome 5
Ancona 4
Bloomington 4
San Giustino Valdarno 4
Bandung 3
Flero 3
Los Angeles 3
Saint-Martin-d'Hères 3
Vernate 3
Washington 3
Arezzo 2
Chandler 2
Clusone 2
Freiburg im Breisgau 2
Genoa 2
Hanover 2
Mainz 2
Padang 2
Seattle 2
Taipei 2
Turin 2
Zhengzhou 2
Amsterdam 1
Andover 1
Borås 1
Chiaravalle 1
Chiari 1
Cornate 1
Davao City 1
Hillsboro 1
Liberty Lake 1
London 1
Lucca 1
Monza 1
Newcastle 1
Segrate 1
Seoul 1
Shenyang 1
Skopje 1
Vienna 1
Walsall 1
Zola Predosa 1
Totale 609
Salva come PNG Salva come JPEG
Nome #
Role of CCL2/MCP-1 in islet transplantation 36
Immunobiology and pathogenesis of hepatitis B virus infection 32
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 28
Inflammatory monocytes hinder antiviral B cell responses 22
Cyclic inhibitors of hepatitis B virus 21
Inhibitors of hepatitis B virus 19
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens 18
Immunosurveillance of the liver by intravascular effector CD8+ T cells 18
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma 17
Extracellular HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV pathogenesis 17
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators 16
Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis 16
Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity 16
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion 16
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 15
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. 15
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming 15
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability 15
Tricyclic inhibitors of hepatitis B virus 15
Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets 14
Bone marrow as an alternative site for islet transplantation 14
Bisphosphonates Target B Cells to Enhance Humoral Immune Responses 14
Bone marrow as an alternative site for islet transplantation 13
T helper-1 lymphocytes mediate liver disease in hepatitis B virus transgenic mice 13
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus 13
Breaking tolerance leads to autoantibody production but not autoimmune liver-disease in hepatitis-B virus envelope transgenic mice 13
Editorial overview: Viral pathogenesis 13
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection 13
Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes 13
Immunological insights in the treatment of chronic hepatitis B 13
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 12
Cytotoxic T-lymphocytes inhibit hepatitis-B virus gene-expression by a noncytolytic mechanism in transgenic mice 12
Altered helper T lymphocyte (HTL) function associated with chronic HBV infection and its role in response to therapeutic vaccination in humans 12
Platelets mediate cytotoxic T lymphocyte-induced liver damage 12
IFN gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment 12
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans 12
A global scientific strategy to cure hepatitis B 12
Protective and Pathogenic T Cell Responses to Virus Infections 12
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier 11
A two hit model of CTL killing in vivo 11
Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 11
Cytokine-mediated control of viral infections 11
The COP9 signalosome is a repressor of replicative stress responses and polyploidization in the regenerating liver 11
HBV Immunopathogenesis 11
Oxalamido-substituted tricyclic inhibitors of hepatitis B virus 11
Cytotoxic T-lymphocyte mediated regulation of hepatitis-B virus gene-expression in-vivo 10
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs 10
Platelets mediate CTL-induced immunopathology in the liver 10
CTL access to tissue antigen is restricted in-vivo 10
Kupffer cells reduce liver immunopathology 10
Cytotoxic T-lymphocytes can clear hepatitis-B virus from the hepatocyte without killing the cell 10
Effector CD8+T cell-derived interleukin-10 enhances acute liver immunopathology 10
Activated intrahepatic antigen presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 10
Host-virus interactions during malaria infection in hepatitis B virus transgenic mice 10
Microcirculation in the murine liver: a computational fluid dynamic model based on 3D reconstruction from in vivo microscopy 10
Class-I restricted cytotoxic T-lymphocytes are directly cytopathic for their target-cells in-vivo 10
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice 9
Nkx2-5+/Islet1+ mesenchymal progenitors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity 9
Different intrahepatic cytoknie priles during acure HBV and HCV infection in the same chimpanzees 9
Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes 9
HBV pathogenesis in animal models: Recent advances on the role of platelets 9
Pathogenesis of hepatitis B virus in transgenic mice 9
On the role of platelets in the pathogenesis of viral hepatitis 9
Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site 9
Mechanisms of class-I restricted immunopathology - a transgenic mouse model of fulminant-hepatitis 9
Platelets mediate clearance of lymphocytic choriomeningitis virus infection preventing lethal hemorrhage 9
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen 9
In vivo flow mapping in complex vessel networks by single image correlation 9
Effector CD8 T cell trafficking within the liver 9
Platelets mediate cytotoxic T lymphocyte-induced liver damage 9
Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation 9
Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes 9
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 9
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis 8
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus 8
Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus 8
The optimization of helper T lymphocyte (HTL) function in vaccine development 8
Hepatitis C virus core and E2 protein expression in transgenic mice 8
Hepatitis-B virus nucleocapsid particles do not cross the hepatocyte nuclear-membrane in transgenic mice 8
Interleukin-2 down-regulates hepatitis-B virus gene-expression in transgenic mice by a posttranscriptional mechanism 8
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes 8
Interleukin-2 and alpha/beta interferon down-regulate hepatitis-B virus gene-expression in-vivo by tumor necrosis factor-dependent and factor-independent pathways 8
Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis 8
Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines 8
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice 8
Hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice 8
The hepatitis B virus X protein transactivates viral core gene expression in vivo 8
Natural killer T cell activation inhibits hepatitis B virus replication in vivo 8
The transgenic mouse model of hepatitis B virus infection 8
Mouse models of hepatitis B virus pathogenesis 8
The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection 8
Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice 8
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study 8
Liver gene expression associated with the inhibition of HBV replication or transcription 7
High-level hepatitis-B virus-replication in transgenic mice 7
To kill or to cure: Options in host defense against viral infection 7
Pathogenetic and antiviral immune responses against hepatitis B virus 7
Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice 7
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes 7
Immune pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice 7
Totale 1.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 3 0 0 2 1 1 0 0 0 0 0 0
2020/202116 0 1 0 3 2 3 5 0 0 2 0 0
2021/2022121 0 0 0 57 2 0 6 3 5 7 5 36
2022/2023846 302 200 62 2 13 118 21 78 31 1 4 14
2023/2024333 22 16 59 114 29 37 13 29 4 10 0 0
Totale 1.406